HP&M’s Dave Clissold to Speak at Management Forum Conference on Drug Regulatory Strategy Matters

Hyman, Phelps & McNamara, P.C. Director David B. Clissold will be speaking at an upcoming Management Forum conference on myriad topics, including orphan drug exclusivity, FDA regulatory strategies, and advanced therapy products.  The conference, titled “EU and US Regulatory Issues for IP Professionals,” will take place on February 4-5, 2013 in Geneva.  A copy of the conference brochure is available here.

FDA Law Blog readers can receive a 20% discount off the registration price of the two-day conference.  To receive the discount, please contact Sarah Packham at sarah.packham@management-forum.co.uk and mention FDA Law Blog.  For more information and to register, visit the conference website.